Company Overview of Grifols Biologicals, Inc.
Grifols Biologicals, Inc. researches, develops, and produces therapeutic proteins from human plasma. The company offers plasma fractioning and produces industrial haemoderivatives. The company also obtains, purifies, and fills albumin vials. The company was founded in 1940 and is based in Los Angeles, California. Grifols Biologicals, Inc. operates as a subsidiary of Grifols, S.A.
5555 Valley Boulevard
Los Angeles, CA 90032
Founded in 1940
Key Executives for Grifols Biologicals, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Grifols Biologicals, Inc., please visit www.grifolsusa.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.